Works cited by this work

34 works

Work: Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans

1. Phytochrome RNAi enhances major fibre quality and agronomic traits of the cotton Gossypium hirsutum L

   Ibrokhim Y. Abdurakhmonov, Zabardast T. Buriev, Sukumar Saha +3

   Article201410 citations

   ABIABI:AkademIndex/openalex/2026.other.196814

2. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan

   Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5

   ArticleSARS-CoV-2 and COVID-19 ResearchPLoS ONE20229 citations

   ABIABI:AkademIndex/openalex/2026.other.232427

3. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

   Lianpan Dai, Tianyi Zheng, Kun Xu +18

   Article20208 citations

   ABIABI:AkademIndex/openalex/2026.other.232416

4. Untitled

   Other8 citations

   ABIABI:AkademIndex/openalex/2026.other.232429

5. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

   Lianpan Dai, Lidong Gao, Lifeng Tao +27

   Article20227 citations

   ABIABI:AkademIndex/openalex/2026.other.232428

6. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

   Shilong Yang, Yan Li, Lianpan Dai +26

   Article20216 citations

   ABIABI:AkademIndex/openalex/2026.other.232420

7. Covid‐19 vaccines and variants of concern: A review

   Ikbel Hadj Hassine

   Review article20214 citations

   ABIABI:AkademIndex/openalex/2026.other.232424

8. A plant‐derived edible vaccine against hepatitis B virus

   Józef Kapusta, A. Modelska, Magdalena Figlerowicz +7

   Article19992 citations

   ABIABI:AkademIndex/openalex/2026.other.232404

9. Novel Transgenic Rice-Based Vaccines

   Tatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono +1

   Review article20142 citations

   ABIABI:AkademIndex/openalex/2026.other.232405

10. Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

    Peter Pushko, Paul Pumpens, Elmars Grens

    Review article20132 citations

    ABIABI:AkademIndex/openalex/2026.other.232407

11. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

    Tomonori Nochi, Hidenori Takagi, Yoshikazu Yuki +11

    Article20072 citations

    ABIABI:AkademIndex/openalex/2026.other.232409

12. Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine

    Natalia Pogrebnyak, Maxim Golovkin, V. M. Andrianov +4

    Article20052 citations

    ABIABI:AkademIndex/openalex/2026.other.232410

13. Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes

    Andreas Günter Lössl, Mohammad Tahir Waheed

    Review article20112 citations

    ABIABI:AkademIndex/openalex/2026.other.232411

14. Current state and challenges in developing oral vaccines

    Julia E. Vela Ramirez, Lindsey A. Sharpe, Nicholas A. Peppas

    Review article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.232413

15. Edible Vaccines: Promises and Challenges

    Vrinda M Kurup, Jaya Thomas

    Review article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.232415

16. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

    Chee Wah Tan, Wan Ni Chia, Xijian Qin +13

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.232417

17. An edible vaccine development for coronavirus disease 2019: the concept

    Sayed Sartaj Sohrab

    Review article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.232418

18. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

    Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj +17

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.232421

19. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

    John S. Tregoning, Katie E. Flight, Sophie L. Higham +2

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.232422

20. Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines

    Puna Maya Maharjan, Sunghwa Choe

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.232423

21. Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

    Dennis Christensen, Charlotta Polacek, Daniel J. Sheward +17

    Article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.232431

22. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic

    Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova +3

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.232432

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.232406

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.232408

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.232412